AVITA Medical Inc
RCEL
Get informed when a big investor buys or sells
+ FollowMarket Cap$469.53M
Close$
$-9.80
173.1% downside
Current Fair Value
173.1% downsideOvervalued by 173.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $469.53 Million |
|---|---|
| Enterprise Value | $462.21 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.74 |
| Beta | 1.99 |
| Outstanding Shares | 30,749,894 |
Return
| Return on Equity | 154.76% |
|---|---|
| Return on Assets | -90.17% |
| Return on Invested Capital | 103.20% |
Valuation & Multiples
| P/E Ratio | -9.11 |
|---|---|
| PEG | 40.04 |
| Price to Sales | 6.71 |
| Price to Book Ratio | -13.41 |
| Enterprise Value to Revenue | 6.11 |
| Enterprise Value to EBIT | -21.39 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | -0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$20.25 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
$22.35 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.4107▲ 141.07% |
|---|---|
| Total Calls | 22,400▼ 99.95% |
| Total Puts | 31,600▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 16.08%▼ 141.85% |
|---|---|
| Total Invested | $20.43M▼ 67.00% |
| Investors Holding | 78▼ 2.00% |
ESG Score
No data
About AVITA Medical Inc
226 employees
CEO: Cary G. Vance AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a de...